Field safety notices: GeneSign Biotech (Xiamen)Co., Ltd.
Manufacturer registered in EUDAMED: SRN CN-MF-000044463 ; country: China
2 authority publications by 2 authorities, from 16 Dec 2025 to 18 Feb 2026.
Latest notice: 18 Feb 2026, BASG, Nicht CE-gekennzeichnete In-vitro-Diagnostika
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by GeneSign Biotech (Xiamen)Co., Ltd. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- Nicht CE-gekennzeichnete In-vitro-Diagnostika
Quelle: BASG (Bundesamt für Sicherheit im Gesundheitswesen), amtliche Nachrichten – Medizinprodukte · collected 17 Nov 2026
- iCare SyphilisModels, lots, UDI: iCare Hepatitis B (HBsAg) ; iCare Gonorrhea ; iCare Chlamydia ; iCare Hepatitis C (HCV) ; iCare Herpes ; iCare HIV Selft Test ; comercializadas bajo el nombre de JAL Medical (Singapore) PTE LTD
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026